These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 29279490)

  • 1. Renal Mucinous Tubular and Spindle Cell Carcinoma Shows a High Uptake on
    Furuya S; Manabe O; Nanbu T; Yamashita N; Shinnno Y; Kasai K; Kroenke M; Tamaki N
    Intern Med; 2018 Apr; 57(8):1131-1134. PubMed ID: 29279490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of renal cell carcinoma histological subtype and fuhrman grade using
    Nakajima R; Nozaki S; Kondo T; Nagashima Y; Abe K; Sakai S
    Eur Radiol; 2017 Nov; 27(11):4866-4873. PubMed ID: 28523353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging of renal cell carcinoma in patients with acquired cystic disease of the kidney: comparison
    Kitajima K; Yamamoto S; Kawanaka Y; Katsuura T; Fujita M; Nakanishi Y; Yamada Y; Hashimoto T; Suzuki T; Go S; Kanematsu A; Nojima M; Yamakado K
    Jpn J Radiol; 2019 Feb; 37(2):165-177. PubMed ID: 30377936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucinous tubular and spindle cell carcinoma (MTSCC) of the kidney: a detailed study of radiological, pathological and clinical outcomes.
    Kenney PA; Vikram R; Prasad SR; Tamboli P; Matin SF; Wood CG; Karam JA
    BJU Int; 2015 Jul; 116(1):85-92. PubMed ID: 25395040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (18)F-fluorodeoxyglucose-positron-emission tomography/computed tomography staging of mucinous tubular and spindle cell carcinoma of the kidney.
    Ozturk H
    Indian J Nucl Med; 2015; 30(1):68-71. PubMed ID: 25589812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical role of early dynamic FDG-PET/CT for the evaluation of renal cell carcinoma.
    Nakajima R; Abe K; Kondo T; Tanabe K; Sakai S
    Eur Radiol; 2016 Jun; 26(6):1852-62. PubMed ID: 26403580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Renal mucinous tubular and spindle cell carcinoma combined with multiple bone metastasis: a case report and literature review].
    Huang ZX; Zhang XP; Dong S; Liu SJ; Yang RL; Zhou YS; Ma WG
    Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Aug; 50(4):732-736. PubMed ID: 30122780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The acceleration of glucose accumulation in renal cell carcinoma assessed by FDG PET/CT demonstrated acquisition of resistance to tyrosine kinase inhibitor therapy.
    Nakaigawa N; Kondo K; Ueno D; Namura K; Makiyama K; Kobayashi K; Shioi K; Ikeda I; Kishida T; Kaneta T; Minamimoto R; Tateishi U; Inoue T; Yao M
    BMC Cancer; 2017 Jan; 17(1):39. PubMed ID: 28068944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced MRI and 18F-FDG PET/CT Findings of Preoperative Primary Renal Collecting Duct Carcinoma.
    Ge J; Zuo C; Guan Y; Liang Z
    Clin Nucl Med; 2016 Dec; 41(12):998-999. PubMed ID: 27775947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ¹⁸F-fluorodeoxyglucose uptake on positron emission tomography in mucinous adenocarcinoma.
    Murakami S; Saito H; Karino F; Kondo T; Oshita F; Ito H; Nakayama H; Yokose T; Yamada K
    Eur J Radiol; 2013 Nov; 82(11):e721-5. PubMed ID: 23988690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal mucinous tubular and spindle cell carcinoma and 18F-fluorodeoxyglucose-PET/CT findings.
    Öztürk H
    Clin Genitourin Cancer; 2014 Aug; 12(4):e161-6. PubMed ID: 24815536
    [No Abstract]   [Full Text] [Related]  

  • 12. A prospective diagnostic accuracy study of F-18 fluorodeoxyglucose-positron emission tomography/computed tomography in the evaluation of indeterminate renal masses.
    Ozülker T; Ozülker F; Ozbek E; Ozpaçaci T
    Nucl Med Commun; 2011 Apr; 32(4):265-72. PubMed ID: 21301376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of 11C-4DST and 18F-FDG PET/CT imaging for advanced renal cell carcinoma: preliminary study.
    Minamimoto R; Nakaigawa N; Nagashima Y; Toyohara J; Ueno D; Namura K; Nakajima K; Yao M; Kubota K
    Abdom Radiol (NY); 2016 Mar; 41(3):521-30. PubMed ID: 27039323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FDG PET/CT of Chromophobe Renal Cell Carcinoma With Sarcomatoid Differentiation.
    Lee CH; Kesari V; Legesse T; Chen W
    Clin Nucl Med; 2018 May; 43(5):367-369. PubMed ID: 29485439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Positron Emission Tomography Imaging in Metabolically Active Renal Cell Carcinoma.
    Karivedu V; Jain AL; Eluvathingal TJ; Sidana A
    Curr Urol Rep; 2019 Aug; 20(10):56. PubMed ID: 31468240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of dual tracer PSMA and FDG PET/CT in renal cell carcinoma (RCC) compared to conventional imaging: A multi-institutional case series with intra-individual comparison.
    Tariq A; Kwok M; Pearce A; Rhee H; Kyle S; Marsh P; Raveenthiran S; Wong D; McBean R; Westera J; Dunglison N; Esler R; Navaratnam A; Yaxley JW; Thomas P; Pattison DA; Roberts MJ
    Urol Oncol; 2022 Feb; 40(2):66.e1-66.e9. PubMed ID: 34895817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mucinous tubular and spindle cell carcinoma of kidney: a clinicopathological study].
    Song HJ; Ma J; Zhou HB; Ma HH; Shi QL; Zhou XJ
    Zhonghua Bing Li Xue Za Zhi; 2011 Jul; 40(7):444-8. PubMed ID: 22088369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal Masses Detected on FDG PET/CT in Patients With Lymphoma: Imaging Features Differentiating Primary Renal Cell Carcinomas From Renal Lymphomatous Involvement.
    Nicolau C; Sala E; Kumar A; Goldman DA; Schoder H; Hricak H; Vargas HA
    AJR Am J Roentgenol; 2017 Apr; 208(4):849-853. PubMed ID: 28095016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of 18F-fluorodeoxyglucose positron-emission tomography/computed tomography for the postoperative surveillance of advanced renal cell carcinoma.
    Park JW; Jo MK; Lee HM
    BJU Int; 2009 Mar; 103(5):615-9. PubMed ID: 19007371
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Kitajima K; Fukushima K; Yamamoto S; Kato T; Odawara S; Takaki H; Kobayashi K; Yamano T; Yamakado K; Nakanishi Y; Kanematsu A; Nojima M; Suzumura K; Hatano E; Fujimoto J; Kihara T; Nakasho K; Hirota S; Hirota S
    Nagoya J Med Sci; 2017 Feb; 79(2):273-277. PubMed ID: 28626263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.